Fact check: Contrary to Trump’s claim, no law required Roger Marshall to sue his patientsOctober 21, 2026
Share Twitter Facebook LinkedIn Email Jefferies has initiated coverage on Welspun Living with a Buy’ rating and a Rs 260 price target, valuing the company at 14x September 2028 estimated EV/EBITDA.Read More